ABUSE LIABILITY OF INTRAVENOUS BUPRENORPHINE/NALOXONE AND BUPRENORPHINE ALONE IN BUPRENORPHINE-MAINTAINED INTRAVENOUS HEROIN ABUSERS
Gorde:
| Egile nagusia: | |
|---|---|
| Beste egile batzuk: | |
| Formatua: | Liburua |
| Hizkuntza: | gaztelania ingelesa |
| Gaiak: | |
| Sarrera elektronikoa: | Path Enlace web pago |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak: ABUSE LIABILITY OF INTRAVENOUS BUPRENORPHINE/NALOXONE AND BUPRENORPHINE ALONE IN BUPRENORPHINE-MAINTAINED INTRAVENOUS HEROIN ABUSERS
- The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
- FINNISH EXPERIENCE WITH BUPRENORPHINE-NALOXONE COMBINATION (SUBOXONE): SURVEY EVALUATIONS WITH INTRAVENOUS DRUG USERS
- PREFERENCE FOR BUPRENORPHINE/NALOXONE AND BUPRENORPHINE AMONG PATIENTS RECEIVING BUPRENORPHINE MAINTENANCE THERAPY IN FRANCE: A PROSPECTIVE, MULTICENTER STUDY
- A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- EFFICACY OF DAILY AND ALTERNATE-DAY DOSING REGIMENS WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET